Hua Medicine Announces Successful H.K. SENSITIZE Study Results at the CBIIC
SHANGHAI, Nov 30, 2024 – (ACN Newswire via SeaPRwire.com) – Hua Medicine (the “Company”, HKEx stock code: 2552) announced today that the Company has successfully completed its SENSITIZE study on the mechanism by which dorzagliatin improves the β-cell glucose sensitivity
More